相似文献
1
Early reperfusion strategy for acute myocardial infarction: a need for clinical implementation.
J Zhejiang Univ Sci B. 2011 Aug;12(8):629-32. doi: 10.1631/jzus.B1101010.
2
Dual liver transplantation.
J Zhejiang Univ Sci B. 2013 Mar;14(3):178-84. doi: 10.1631/jzus.B1200041.
3
Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology.
Eur Heart J. 2005 Dec;26(24):2733-41. doi: 10.1093/eurheartj/ehi673. Epub 2005 Nov 25.
4
[Reperfusion in ST elevation myocardial infarction. From the guidelines to practice].
Ann Cardiol Angeiol (Paris). 2014 Nov;63(5):312-20. doi: 10.1016/j.ancard.2014.09.001. Epub 2014 Sep 19.
5
ST-segment resolution and prognosis after facilitated versus primary percutaneous coronary intervention in acute myocardial infarction: a meta-analysis.
Clin Res Cardiol. 2010 Jan;99(1):1-11. doi: 10.1007/s00392-009-0068-3. Epub 2009 Aug 29.
6
Reperfusion strategies in ST-segment elevation myocardial infarction.
Minerva Med. 2013 Aug;104(4):391-411.
7
Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
Am J Cardiol. 2014 Oct 1;114(7):955-61. doi: 10.1016/j.amjcard.2014.05.069. Epub 2014 Jul 16.
8
Impact of reperfusion strategy on outcomes in very elderly patients with acute myocardial infarction.
Minerva Cardioangiol. 2014 Dec;62(6):473-9.
9
10
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.
Eur Heart J. 2010 Apr;31(8):943-57. doi: 10.1093/eurheartj/ehp492. Epub 2009 Nov 19.
引用本文的文献
1
Identification and validation of apoptosis-related genes in acute myocardial infarction based on integrated bioinformatics methods.
PeerJ. 2024 Dec 4;12:e18591. doi: 10.7717/peerj.18591. eCollection 2024.
2
Expression characteristics of lipid metabolism-related genes and correlative immune infiltration landscape in acute myocardial infarction.
Sci Rep. 2024 Jun 18;14(1):14095. doi: 10.1038/s41598-024-65022-3.
3
Barriers to Participation in Cardiac Rehabilitation Among Patients with Coronary Heart Disease After Reperfusion Therapy: A Scoping Review.
Vasc Health Risk Manag. 2023 Aug 31;19:557-570. doi: 10.2147/VHRM.S425505. eCollection 2023.
4
Expression pattern and diagnostic value of ferroptosis-related genes in acute myocardial infarction.
Front Cardiovasc Med. 2022 Nov 3;9:993592. doi: 10.3389/fcvm.2022.993592. eCollection 2022.
5
CircUBXN7 mitigates H/R-induced cell apoptosis and inflammatory response through the miR-622-MCL1 axis.
Am J Transl Res. 2021 Aug 15;13(8):8711-8727. eCollection 2021.
6
Rationale and design of the Henan ST elevation myocardial infarction (STEMI) registry: a regional STEMI project in predominantly rural central China.
BMC Cardiovasc Disord. 2019 Nov 28;19(1):271. doi: 10.1186/s12872-019-1250-9.
7
Chest Pain Center Accreditation Is Associated With Improved In-Hospital Outcomes of Acute Myocardial Infarction Patients in China: Findings From the CCC-ACS Project.
J Am Heart Assoc. 2019 Nov 5;8(21):e013384. doi: 10.1161/JAHA.119.013384. Epub 2019 Oct 19.
8
Fragmented QRS (fQRS) Complex Predicts Adverse Cardiac Events of ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention and Thrombolysis.
Med Sci Monit. 2018 Jul 5;24:4634-4640. doi: 10.12659/MSM.908712.
9
10
Patients with ST-segment elevation of myocardial infarction miss out on early reperfusion: when to undergo delayed revascularization.
J Geriatr Cardiol. 2017 Aug;14(8):524-531. doi: 10.11909/j.issn.1671-5411.2017.08.006.
本文引用的文献
1
[Guideline for diagnosis and treatment of patients with ST-elevation myocardial infarction].
Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Aug;38(8):675-90.
2
Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
Eur Heart J. 2011 Apr;32(8):972-82. doi: 10.1093/eurheartj/ehq398. Epub 2010 Oct 28.
3
Guidelines on myocardial revascularization.
Eur Heart J. 2010 Oct;31(20):2501-55. doi: 10.1093/eurheartj/ehq277. Epub 2010 Aug 29.
4
Current status and development of percutaneous coronary intervention in China.
J Zhejiang Univ Sci B. 2010 Aug;11(8):631-3. doi: 10.1631/jzus.B1001012.
5
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.
Eur Heart J. 2010 Apr;31(8):943-57. doi: 10.1093/eurheartj/ehp492. Epub 2009 Nov 19.
6
Facilitated PCI in patients with ST-elevation myocardial infarction.
N Engl J Med. 2008 May 22;358(21):2205-17. doi: 10.1056/NEJMoa0706816.
7
Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go.
Eur Heart J. 2008 Mar;29(5):609-17. doi: 10.1093/eurheartj/ehn069.
8
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
Lancet. 2007 Sep 15;370(9591):937-48. doi: 10.1016/S0140-6736(07)61444-5.
9
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.
Lancet. 2006 Feb 18;367(9510):569-78. doi: 10.1016/S0140-6736(06)68147-6.
10
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
Lancet. 2003 Jan 4;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.
Zotero 插件